China Pharma Holdings, Inc. Announces Conference Call to Discuss Second Quarter 2007 Results

HAIKOU CITY, China, Aug. 9 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) today announced that the Company will host a conference call at 11:00 am EST on Tuesday, August 14, 2007, to discuss results for the second quarter of 2007.

Joining Ms. Zhilin Li, President and CEO of China Pharma, will be Mr. Xinhua Wu, Chief Financial Officer, and Mr. William Li, Spokesman. The Company plans to release its earnings earlier the same day.

To participate in the conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: (866) 831-6270. International callers should dial (617) 213-8858. The conference passcode is 67882959.

If you are unable to participate in the call at this time, a replay will be available on Tuesday, August 14 at 1:00 pm EST, through Tuesday, August 21 at 1:00 pm EST. To access the replay, dial (888) 286-8010. International callers should dial (617) 801-6888. The conference passcode is 88502129.

The conference will be broadcast live over the Internet and can be accessed by all interested parties at China Pharma's website at http://www.chinapharmaholdings.com . To listen to the call, please go to the website at least 15 minutes prior to the start of the call to register, download and install any necessary audio software.

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd (Helpson), a specialty bio-pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly-owned subsidiary of China Pharma Holdings.

For more information, please contact:

Sophia Yu

China Pharma Holdings, Inc.

Phone: +86-898-6681-1730

Email: hps@chinapharmaholdings.com